
The high prices of prescription drugs have sparked criticism from various figures, including Senator Jeff Merkley and Senator Elizabeth Warren, who advocate for fair drug pricing. Calls for transparency in drug pricing have been echoed by Representative Katie Porter, highlighting the need for Americans to know the cost of their medications. The pharmaceutical industry faces scrutiny for deceptive practices, such as omitting drug prices in advertisements, prompting legislative action to increase transparency.
Solid, short take on GLP-1 budget impact: https://t.co/FURTMxFNBh by @TreedinDC @axios But in big market like this, shouldn’t pts switching out of pvt plans ~ pts switching in? (Except when pts transition to Medicare, obvi. But that’s not the argument that’s being made here.) https://t.co/jGBkH576vR
🚨 Russell 2000 Rebalancing - April 30th $XBI
$XBI $DCPH buyout Reverse jinxing started to work! https://t.co/8QPWCyfiVs




